CN102753567A - Mybl2肽及包含它们的疫苗 - Google Patents

Mybl2肽及包含它们的疫苗 Download PDF

Info

Publication number
CN102753567A
CN102753567A CN2010800635724A CN201080063572A CN102753567A CN 102753567 A CN102753567 A CN 102753567A CN 2010800635724 A CN2010800635724 A CN 2010800635724A CN 201080063572 A CN201080063572 A CN 201080063572A CN 102753567 A CN102753567 A CN 102753567A
Authority
CN
China
Prior art keywords
peptides
cancer
peptide
cells
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800635724A
Other languages
English (en)
Chinese (zh)
Inventor
中村佑辅
角田卓也
大泽龙司
吉村祥子
渡边朝久
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of CN102753567A publication Critical patent/CN102753567A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2010800635724A 2009-12-04 2010-12-02 Mybl2肽及包含它们的疫苗 Pending CN102753567A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26687109P 2009-12-04 2009-12-04
US61/266,871 2009-12-04
PCT/JP2010/007028 WO2011067933A1 (en) 2009-12-04 2010-12-02 Mybl2 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
CN102753567A true CN102753567A (zh) 2012-10-24

Family

ID=44114795

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800635724A Pending CN102753567A (zh) 2009-12-04 2010-12-02 Mybl2肽及包含它们的疫苗

Country Status (14)

Country Link
US (1) US20120328638A1 (enExample)
EP (1) EP2507257A4 (enExample)
JP (1) JP2013512659A (enExample)
KR (1) KR20120114284A (enExample)
CN (1) CN102753567A (enExample)
AU (1) AU2010327891A1 (enExample)
BR (1) BR112012013371A2 (enExample)
CA (1) CA2782484A1 (enExample)
IL (1) IL219927A0 (enExample)
MX (1) MX2012006376A (enExample)
RU (1) RU2012127762A (enExample)
SG (1) SG181108A1 (enExample)
TW (1) TW201200525A (enExample)
WO (1) WO2011067933A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119859688A (zh) * 2025-01-20 2025-04-22 杭州树源生命科学有限公司 环状RNA Hsa_circ_0006332在食管鳞状细胞癌诊断和治疗中的应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108623657B (zh) * 2018-05-11 2021-02-12 苏州大学 多肽、重组dna分子、重组载体、外泌体及其应用
WO2024209270A2 (en) * 2023-04-07 2024-10-10 Infinitopes Limited Methods and compositions for cancer treatment using recombinant polypeptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100352842C (zh) * 2002-10-31 2007-12-05 詹森药业有限公司 对促肾上腺皮质激素释放激素刺激的应答而表达增加的基因
WO2009001562A1 (en) * 2007-06-27 2008-12-31 Oncotherapy Science, Inc. Compositions and methods of treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514084B2 (en) * 2002-09-12 2009-04-07 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
PT2325305E (pt) * 2005-02-25 2014-04-29 Oncotherapy Science Inc Vacinas peptídicas para cancros do pulmão que expressam polipéptidos ttk, urlc10 ou koc1
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100352842C (zh) * 2002-10-31 2007-12-05 詹森药业有限公司 对促肾上腺皮质激素释放激素刺激的应答而表达增加的基因
WO2009001562A1 (en) * 2007-06-27 2008-12-31 Oncotherapy Science, Inc. Compositions and methods of treating cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119859688A (zh) * 2025-01-20 2025-04-22 杭州树源生命科学有限公司 环状RNA Hsa_circ_0006332在食管鳞状细胞癌诊断和治疗中的应用

Also Published As

Publication number Publication date
EP2507257A1 (en) 2012-10-10
US20120328638A1 (en) 2012-12-27
TW201200525A (en) 2012-01-01
RU2012127762A (ru) 2014-01-10
SG181108A1 (en) 2012-07-30
JP2013512659A (ja) 2013-04-18
EP2507257A4 (en) 2013-04-03
IL219927A0 (en) 2012-07-31
AU2010327891A1 (en) 2012-06-21
MX2012006376A (es) 2012-07-10
KR20120114284A (ko) 2012-10-16
BR112012013371A2 (pt) 2016-12-13
WO2011067933A1 (en) 2011-06-09
CA2782484A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
CN105164256B (zh) Kntc2肽及包含它们的疫苗
CN102356155B (zh) Neil3肽及包含它的疫苗
CN104066746B (zh) Topk肽及包含它们的疫苗
CN102947325B (zh) Cdca5肽及包含它们的疫苗
CN102822193B (zh) 修饰的melk肽及包含它们的疫苗
CN103732743B (zh) Mphosph1肽及包含它们的疫苗
CN103620033A (zh) Sema5b肽及包含它们的疫苗
CN102459314B (zh) Ttk肽及包含它们的疫苗
CN103339253B (zh) Tomm34肽及包含它们的疫苗
CN103189510B (zh) Ttll4肽及包含它们的疫苗
CN102884190B (zh) Hjurp肽及包含它们的疫苗
CN102939379B (zh) Ect2肽及包含它们的疫苗
US8697631B2 (en) TMEM22 peptides and vaccines including the same
WO2011067933A1 (en) Mybl2 peptides and vaccines containing the same
CN103282494B (zh) C18orf54肽及包含它们的疫苗
CN103270156B (zh) Wdhd1肽及包含它们的疫苗
HK1176365B (en) Modified melk peptides and vaccines containing the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121024